strong rebound woe
clear yet
come well ahead key metric
sale ahead guid our/street estim
shipment yoy ahead guid
bofaml estim itero scanner servic sequenti due
strong result still grew yoy align made
differ importantli align came ahead case shipment bogey gain
price came ahead vs bofaml estim margin
roughli line gross margin line opm although opm
benefit due earli termin invisalign store leas ep
ahead bofaml estim street guid
updat model follow result
sign busi stabil like never happen
issu crop result quarter flashback steadi
execut display strong balanc volum growth
intern market incl particularli robust perform latin america japan
gradual recoveri china steadi result north america given tough comp
promot improv major red flag competit
chang materi off-set improv execut
increas sg spend advertis sponsorship partnership drove bump
quit wood
result give us increas confid execut reiter
neutral rate main concern remain long-term outlook sale growth
opm whether align recaptur break-out also note
guid came ahead expect bar lower
significantli miss three month ago consensu
sale vs current guid expect share move tomorrow
result part due short squeez short interest rais po
p/ vs prior acknowledg
improv execut
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
align domin compani clear align
orthodont market invisalign brand
compet tradit metal brace also
known wire bracket align revenu
come primarili famili clear align
product case use treat malocclus
crook teeth dental cosmet
medic issu well digit scanner
servic non-cas product retain
ancillari offer
align view potenti one
best growth stori healthcar
compani invisalign franchis continu take
market share tradit brace bracket
increment concern competit well
appar less visibl busi
end-custom demand neutral rate
po base roughli p/ roughli line compani
prior multipl period volatil uncertainti believ multipl
justifi given strong growth profil substanti opportun estim
sale compound-annual-growth-rate next five year yet reflect increment question
concern competit end-custom demand notabl multipl still slight
premium long-term histor multipl
downsid risk price object competit exist new clear
align manufactur slower macroeconom condit multipl contract due
fund flow de-risk move
upsid risk improv commerci perform new product launch benefit
increas sale market stronger macroeconomic/consum sentiment
michael ryskin herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us life scienc diagnost tool anim health coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
